Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Phosphatidylinositol 3-kinase signaling determines kidney size
Jian-Kang Chen, … , Eric G. Neilson, Raymond C. Harris
Jian-Kang Chen, … , Eric G. Neilson, Raymond C. Harris
Published May 18, 2015
Citation Information: J Clin Invest. 2015;125(6):2429-2444. https://doi.org/10.1172/JCI78945.
View: Text | PDF
Research Article Nephrology

Phosphatidylinositol 3-kinase signaling determines kidney size

  • Text
  • PDF
Abstract

Kidney size adaptively increases as mammals grow and in response to the loss of 1 kidney. It is not clear how kidneys size themselves or if the processes that adapt kidney mass to lean body mass also mediate renal hypertrophy following unilateral nephrectomy (UNX). Here, we demonstrated that mice harboring a proximal tubule–specific deletion of Pten (PtenptKO) have greatly enlarged kidneys as the result of persistent activation of the class I PI3K/mTORC2/AKT pathway and an increase of the antiproliferative signals p21Cip1/WAF and p27Kip1. Administration of rapamycin to PtenptKO mice diminished hypertrophy. Proximal tubule–specific deletion of Egfr in PtenptKO mice also attenuated class I PI3K/mTORC2/AKT signaling and reduced the size of enlarged kidneys. In PtenptKO mice, UNX further increased mTORC1 activation and hypertrophy in the remaining kidney; however, mTORC2-dependent AKT phosphorylation did not increase further in the remaining kidney of PtenptKO mice, nor was it induced in the remaining kidney of WT mice. After UNX, renal blood flow and amino acid delivery to the remaining kidney rose abruptly, followed by increased amino acid content and activation of a class III PI3K/mTORC1/S6K1 pathway. Thus, our findings demonstrate context-dependent roles for EGFR-modulated class I PI3K/mTORC2/AKT signaling in the normal adaptation of kidney size and PTEN-independent, nutrient-dependent class III PI3K/mTORC1/S6K1 signaling in the compensatory enlargement of the remaining kidney following UNX.

Authors

Jian-Kang Chen, Kojiro Nagai, Jianchun Chen, David Plieth, Masayo Hino, Jinxian Xu, Feng Sha, T. Alp Ikizler, C. Chad Quarles, David W. Threadgill, Eric G. Neilson, Raymond C. Harris

×

Figure 7

Simultaneous deletion of proximal tubule EGFR decreases the renal hypertrophy and AKT/mTOR signaling seen in PtenptKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Simultaneous deletion of proximal tubule EGFR decreases the renal hypert...
(A) Schematic diagram depicting the generation of Egfr and Pten double-KO mice with the Egfrfl/fl Ptenfl/fl phenotype (abbreviated as Egfr PtenptDKO). Deletion of both Pten and Egfr was confirmed by PCR and immunoblot analysis (data not shown). (B) The increased kidney/BW ratio in PtenptKO mice was partially inhibited in Egfr PtenptDKO mice. ANOVA with Bonferroni’s t correction was used for statistical analysis of the data. The indicated P values were calculated from 6 to 10 mice per group. (C and D) The increased levels of AKT (C) and S6K1 (D) seen in the kidneys of PtenptKO mice were both partially inhibited in Egfr PtenptDKO mice. Shown are representative immunoblots for 6 to 10 mice per group with similar results. There were no differences in kidney/BW ratio among the 3 control mice: EgfrCtrl (Egfrfl/fl), PtenCtrl (Ptenfl/fl), and double-control Egfr PtenDCtrl (Egfrfl/fl Ptenfl/fl).
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts